Additional file 2: Table S2. of Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

Multivariate analysis on the determinants of the plasma aldosterone concentration during placebo and during losartan treatment. In this table we illustrate the association between creatinine clearance and the plasma aldosterone concentration during placebo and losartan treatment, while adjusting for age and gender. (DOCX 13 kb